INVESTORS & MEDIA

Dr. Schenkein has been a director of the company since 2023 and is a General Partner and Co-lead of the Life Sciences team at GV (Google Ventures). Prior to joining GV in 2019, Dr. Schenkein served as Chief Executive Officer for Agios Pharmaceuticals for ten years. He previously served in clinical leadership roles at major biotechnology companies including Senior Vice President, Clinical Hematology/Oncology at Genentech and Senior Vice President, Clinical Research at Millennium Pharmaceuticals. Since 2009, Dr. Schenkein has also served as Adjunct Clinical Professor of Medicine, Hematology/Oncology at Tufts Medical Center. He is currently a Board Member of Prime Medicine, Denali Therapeutics and Agios. Dr. Schenkein earned his M.D. at the State University of New York Upstate Medical School in Syracuse and completed his medical training at the Tufts University School of Medicine.